Bayer Cropscience Limited in UTI - Long Term Advantage Fund Series VI · equitylore

Bayer Cropscience Limited · in UTI - Long Term Advantage Fund Series VI

Bayer Cropscience Limited in UTI - Long Term Advantage Fund Series VI

Held in 41 of the fund’s 42 disclosed months. Last held in Jul 2021.

Last weight

2.69%

₹7.8 Cr in Jul 2021

Weight over time

Share of the fund's portfolio each month. A gap is a month the fund disclosed without this stock.

Weight of Bayer Cropscience Limited in UTI - Long Term Advantage Fund Series VI, Feb 2018 to Aug 2021.

New entered Feb 2018 (held from the first disclosure)Exited exited after Jul 202141 months · peak 5.38%

Weight, value and quantity by month
Month	Weight	Value	Shares	Δ shares
Aug 2021	not held
Jul 2021	2.69%	₹7.8 Cr	13,494
Jun 2021	2.58%	₹7.8 Cr	13,494
May 2021	2.28%	₹7.1 Cr	13,494
Apr 2021	2.34%	₹7.2 Cr	13,494	−223
Mar 2021	2.26%	₹7.3 Cr	13,717
Feb 2021	2.02%	₹7.1 Cr	13,717	−3,629
Jan 2021	2.54%	₹9.3 Cr	17,346	−7,583
Dec 2020	3.24%	₹13.6 Cr	24,929